Germline Testing for Predisposition to Ovarian/Breast Cancer Should be Routinely Recommended in all Patients with Invasive Epithelial Ovarian Cancer
Crossref DOI link: https://doi.org/10.1007/s40944-017-0164-7
Published Online: 2017-12-18
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wheeler, Lindsay J.
Guntupalli, Saketh
License valid from 2017-12-01
